The Claim
Consumption of milk containing A1 beta-casein is associated with reduced serum glutathione levels in humans, and parallel reductions in glutathione levels are observed in brain, liver, and gut tissues of animal models fed A1 beta-casein.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Drinking milk with A1 beta-casein is linked to lower levels of glutathione in human blood and in the brain, liver, and gut of animals fed the same protein.
See the scientific wording
Consumption of milk containing A1 beta-casein is associated with reduced serum glutathione levels in humans (n=45, p<0.05), which may contribute to increased oxidative stress, as supported by parallel findings of decreased glutathione in brain, liver, and gut tissues of animal models fed A1 beta-casein.
When milk with A1 beta-casein is digested, it releases a peptide called BCM-7. This peptide binds to opioid receptors in the gut and brain, which blocks the absorption of cysteine, a building block needed to make glutathione. Without enough cysteine, the body cannot produce sufficient glutathione, leading to lower levels of this key antioxidant in the blood, liver, gut, and brain. This causes oxidative stress to rise.
What the research says
1 studyPeople who drank milk with A1 beta-casein had lower levels of glutathione—a key antioxidant—in their blood, just like the claim said. Animals fed the same milk showed the same drop in glutathione in their brain, liver, and gut, which helps explain why this might happen.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.